Chiara Maniaci

Chiara graduated in Pharmaceutical Chemistry and Technology from the University of Messina in 2013, focusing on iron chelators for treatment Parkinson’s disease.

In 2014, she began her PhD at the University of Dundee, where she discovered CM11, a chemical tool for VHL self-degradation. CM11 is now commercially available. After the award of her PhD in 2017 and a post-doc in Dundee, Chiara joined Oxford in 2018 to study epigenetics.

In 2020, she received a BBSRC Discovery Fellowship and moved to Newcastle University to research protein modifications. She started her research group at the MRC Protein Phosphorylation and Ubiquitination Unit, University of Dundee, in January 2023 and in 2024 she was awarded a Royal Society Research Fellowship.